LYMPHOPROLIFERATIVE DISEASE IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL-INJECTED SCID MICE .1. LYMPHOCYTE-T REQUIREMENT FOR B-CELL TUMOR GENERATION

被引:87
作者
VERONESE, ML
VERONESI, A
DANDREA, E
DELMISTRO, A
INDRACCOLO, S
MAZZA, MR
MION, M
ZAMARCHI, R
MENIN, C
PANOZZO, M
AMADORI, A
CHIECOBIANCHI, L
机构
[1] UNIV PADUA,INST ONCOL,INTERUNIV CTR RES CANC,VIA GATTAMELATA 64,I-35128 PADUA,ITALY
[2] IST SCI STUDIO & CURA TUMORI,BIOTECHNOL SECT,I-35128 PADUA,ITALY
关键词
D O I
10.1084/jem.176.6.1763
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mechanisms of tumor development were studied in SCID mice injected with human lymphoid cells from Epstein-Barr virus-positive (EBV+) donors. About 80% of peripheral blood mononuclear cell (PBMC)-injected animals developed a lymphoproliferative disease associated with oligoclonal EBV+ tumors of human B cell origin. No change in tumor development rate occurred when monocyte-depleted PBMC were inoculated. No tumors developed when purified B cells were injected. B cell lymphoproliferative disease was also prevented in most cases when PBMC-injected animals were treated with agents that prevent T cell activation, such as cyclosporin A. Both CD4+ and CD8+ T cell subpopulations were able to provide putative factor(s) necessary for EBV+ B cell expansion and progression to tumors. These data suggest that the transfer alone of potentially tumorigenic human cells into an immunodeficient environment, such as the SCID mouse, might not be sufficient for cell progression to tumor, and raise the possibility that chronic activation events could play a major role in the pathogenesis of some EBV+ lymphomas in the immunocompromised host.
引用
收藏
页码:1763 / 1767
页数:5
相关论文
共 29 条
  • [11] NUCLEAR-ASSOCIATION OF A T-CELL TRANSCRIPTION FACTOR BLOCKED BY FK-506 AND CYCLOSPORINE-A
    FLANAGAN, WM
    CORTHESY, B
    BRAM, RJ
    CRABTREE, GR
    [J]. NATURE, 1991, 352 (6338) : 803 - 807
  • [12] IMMUNOLOGICAL INDUCTION OF MALIGNANT LYMPHOMA - IDENTIFICATION OF DONOR AND HOST TUMORS IN GRAFT VERSUS HOST MODEL
    GLEICHMANN, E
    GLEICHMANN, H
    SCHWARTZ, RS
    WEINBLATT, A
    ARMSTRONG, MYK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 54 (01) : 107 - 116
  • [13] CYCLOSPORINE-A RENDERS TARGET-CELLS RESISTANT TO IMMUNE CYTOLYSIS
    HUDNALL, SD
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (01) : 221 - 226
  • [14] Ioachim H L, 1990, Adv Cancer Res, V54, P301
  • [15] KOSUGI A, 1991, J IMMUNOL, V146, P1416
  • [16] THE SCID-HU MOUSE - MURINE MODEL FOR THE ANALYSIS OF HUMAN HEMATOLYMPHOID DIFFERENTIATION AND FUNCTION
    MCCUNE, JM
    NAMIKAWA, R
    KANESHIMA, H
    SHULTZ, LD
    LIEBERMAN, M
    WEISSMAN, IL
    [J]. SCIENCE, 1988, 241 (4873) : 1632 - 1639
  • [17] TRANSFER OF A FUNCTIONAL HUMAN IMMUNE-SYSTEM TO MICE WITH SEVERE COMBINED IMMUNODEFICIENCY
    MOSIER, DE
    GULIZIA, RJ
    BAIRD, SM
    WILSON, DB
    [J]. NATURE, 1988, 335 (6187) : 256 - 259
  • [18] ROLE OF EPSTEIN-BARR-VIRUS AND INTERLEUKIN-6 IN THE DEVELOPMENT OF LYMPHOMAS OF HUMAN-ORIGIN IN SCID MICE ENGRAFTED WITH HUMAN TONSILLAR MONONUCLEAR-CELLS
    NADAL, D
    ALBINI, B
    SCHLAPFER, E
    BERNSTEIN, JM
    OGRA, PL
    [J]. JOURNAL OF GENERAL VIROLOGY, 1992, 73 : 113 - 121
  • [19] MULTIPLE MONOCLONAL B-CELL EXPANSIONS AND C-MYC ONCOGENE REARRANGEMENTS IN ACQUIRED IMMUNE-DEFICIENCY SYNDROME-RELATED LYMPHOPROLIFERATIVE DISORDERS - IMPLICATIONS FOR LYMPHOMAGENESIS
    PELICCI, PG
    KNOWLES, DM
    ARLIN, ZA
    WIECZOREK, R
    LUCIW, P
    DINA, D
    BASILICO, C
    DALLAFAVERA, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (06) : 2049 - 2060
  • [20] PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431